Herbas VPB

Print
EN | LT
LT - Deoksinukleozidų terapija, skirta gydyti ligas, kurias sukelia nesubalansuoti nukleotidų kiekiai, įskaitant mitochondrinės DNR išsekimo sindromus
EN - DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/7068 (2006.01)
A61K 31/7064 (2006.01)
A61K 31/7072 (2006.01)
A61P 21/00 (2006.01)
A61P 43/00 (2006.01)
A61K 31/513 (2006.01)
A61K 31/7076 (2006.01)
A61K 31/708 (2006.01)
European patent
(11) Number of the document 3505174
(13) Kind of document T
(96) European patent application number 19156021.8
Date of filing the European patent application 2016-06-17
(97) Date of publication of the European application 2019-07-03
(45) Date of publication and mention of the grant of the patent 2020-04-29
(46) Date of publication of the claims translation 2020-09-10
Priority applications
(30) Number Date Country code
201562180914 P 2015-06-17 US
Inventors
(72)
HIRANO, Michio, US
GARONE, Caterina, GB
MARTI, Ramon, ES
Grantee
(73) The Trustees of Columbia University in the City of New York, 412 Low Memorial Library 535 West 116th Street, New York, NY 10027, US
Attorney or representative
(74) Otilija KLIMAITIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Deoksinukleozidų terapija, skirta gydyti ligas, kurias sukelia nesubalansuoti nukleotidų kiekiai, įskaitant mitochondrinės DNR išsekimo sindromus
  DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
Last renewal fee
Payment date Validity (years) Amount
2025-05-23 10 231.00 EUR
Next renewal fee
2026-06-17